Production (Stage)
Bicycle Therapeutics plc
BCYC
$8.05
-$0.05-0.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.85% | 6.44% | -2.93% | -18.13% | -35.38% |
| Total Depreciation and Amortization | 7.57% | 9.59% | 13.48% | 13.50% | 37.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.24% | -16.96% | 6.95% | 90.77% | 94.98% |
| Change in Net Operating Assets | -137.88% | -143.63% | -197.14% | -171.73% | 691.60% |
| Cash from Operations | -111.82% | -171.70% | -364.19% | -237.79% | 19.82% |
| Capital Expenditure | -116.98% | 57.84% | 78.78% | 85.53% | 94.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -116.98% | 57.84% | 78.78% | 85.53% | 94.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 120.66% | 120.66% | 115.97% | 3,635.07% | 2,681.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 107.82% | 107.88% | 103.47% | 3,635.07% | 2,681.03% |
| Foreign Exchange rate Adjustments | -60.17% | -151.56% | -34.20% | -111.62% | 845.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.20% | 88.00% | 50.96% | 2,021.94% | 244.18% |